Trials / Completed
CompletedNCT01490177
Single Center Food Allergy Oral Immunotherapy Study
Single Center, Phase I Food Allergy Oral Immunotherapy Study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 4 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The Primary Objective of the study is to develop a customized regimen for oral immunotherapy that reflects what the subject is allergic in a clinically significant way (i.e., the offending food allergen is defined as a food allergen with a positive skin test or positive specific IgE and a positive DBPCFC). Therefore, the investigators prefer that both single and multiple food allergy subjects are included in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Food proteins | Oral ingestion of Food proteins |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2011-12-12
- Last updated
- 2015-11-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01490177. Inclusion in this directory is not an endorsement.